| STYLIZED A, AARDVARK THERAPEUTICS AARDVARK THERAPEUTICS, INC.
98857689 17 Nov 2024 | on 17 Nov 2024 | Therapeutics and clinical programs targeting neuro-psychological disor... Class 005 Class 005 Pharmaceutical Products Therapeutics and clinical programs targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds for cancer treatment and management; abuse-deterrent pharmaceutical formulations Class 042 Class 042 Computer & Software Services & Scientific Services The mark consists of the wording "aardvark therapeutics" in lower-case spelling with a stylized letter A to the left of the wording. | | | AARDVARK THERAPEUTICS AARDVARK THERAPEUTICS, INC.
98857292 16 Nov 2024 | on 16 Nov 2024 | Therapeutics and clinical programs targeting neuro-psychological disor... Class 005 Class 005 Pharmaceutical Products Therapeutics and clinical programs targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds for cancer treatment and management; abuse-deterrent pharmaceutical formulations Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research and development in the field of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, and rare conditions; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; design and conduct of clinical trials for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions | |